dc.date.accessioned2020-12-14T16:06:32Z
dc.date.available2020-12-14T16:06:32Z
dc.date.created2020-12-14T16:06:32Z
dc.date.issued2020
dc.identifierhttps://hdl.handle.net/20.500.12866/8734
dc.identifierhttps://doi.org/10.17458/per.vol17.2020.mps.type1diabetescomparison
dc.description.abstractGlobally it is estimated that over 1 million children and adolescents have Type 1 diabetes with large variations in incidence between different contexts. Health systems need to provide a variety of elements to ensure appropriate diabetes care, such as service delivery; healthcare workforce; information; medical products and technologies; financing and leadership and governance. Describing these elements between Geneva, Switzerland, a high-income country with high spending on healthcare and a large density of doctors, and low- and middle-income countries this article aims to highlight the global inequality of diabetes care. Type 1 diabetes can serve as a litmus as we move towards the centenary of the discovery of insulin and beyond as there is a need for a global movement to ensure that innovation in the management of diabetes benefits the whole diabetes community and not just a select few.
dc.languageeng
dc.publisherYS Medical Media
dc.relationPediatric Endocrinology Review
dc.relation1565-4753
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectAccess
dc.subjectInsulin
dc.subjectType 1 diabetes
dc.titleGlobal Inequality in Type 1 Diabetes: a Comparison of Switzerland and Low-and Middle-Income Countries
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución